Nutritional Interventions for the Prevention of Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer Disease: Protocol for a Network Meta-Analysis of Randomized Controlled Trials
BackgroundMild cognitive impairment (MCI) is the stage between cognitive decline due to physiological aging and the severity of decline seen in neurodegenerative disorders like Alzheimer disease (AD), which is among the most prevalent neurodegenerative disorders characterized...
Main Authors: | Qian He, Kevin Chun Hei Wu, Adam N Bennett, Jia Yue Zhang, Kei Hang Katie Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2024-02-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2024/1/e47196 |
Similar Items
-
Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer’s Disease
by: Jingjing Guan, et al.
Published: (2020-03-01) -
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
by: Pia Kivisäkk, et al.
Published: (2023-03-01) -
Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
by: Corinna M. Bauer, et al.
Published: (2018-02-01) -
Functional Connectivity Changes Across the Spectrum of Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment and Alzheimer’s Disease
by: Ziqi Wang, et al.
Published: (2019-04-01) -
Predicting cognitive decline in mild cognitive impairment: the issue of biological markers
by: Giannakopoulos Panteleimon
Published: (2006-02-01)